Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sernova is a regenerative medicine clinical-stage company developing its proprietary Cell Pouch System, an implantable device containing immune-protected therapeutic cells for chronic diseases. The lead product targets type 1 diabetes by delivering insulin-producing cells, aiming to provide a functional cure rather than symptomatic treatment.
investor_presentation
32 Pages
investor_presentation
26 Pages
AZZ
GM Financial Strategic Operational Overview 2021
investor_presentationinvestor_presentation
21 Pages
General Motors Financial Company